Mangoceuticals Files 2024 Annual Report

Ticker: MGRX · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1938046

Mangoceuticals, INC. 10-K Filing Summary
FieldDetail
CompanyMangoceuticals, INC. (MGRX)
Form Type10-K
Filed DateMar 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

Mangoceuticals dropped its 2024 10-K. Full year financials are in.

AI Summary

Mangoceuticals, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Texas, operates in the health services sector. Key financial data and operational details for the fiscal year 2024 are presented in this filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Mangoceuticals' financial performance and business operations for the fiscal year 2024, including key financial statements and risk factors.

Risk Assessment

Risk Level: medium — As a 10-K filing, it inherently contains detailed financial information and risk disclosures typical for public companies, requiring careful review.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Mangoceuticals, Inc.?

Mangoceuticals, Inc. operates in the Services-Misc Health & Allied Services, NEC sector, SIC code 8090.

When was the 10-K filing submitted to the SEC?

The 10-K filing was submitted on March 20, 2025.

What is the SEC file number for Mangoceuticals, Inc.?

The SEC file number for Mangoceuticals, Inc. is 001-41615.

Where is Mangoceuticals, Inc. headquartered?

Mangoceuticals, Inc. is headquartered at 15110 Dallas Pkwy, Suite 600, Dallas, TX 75248.

What fiscal year does this 10-K report cover?

This 10-K report covers the fiscal year ending December 31, 2024.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding MANGOCEUTICALS, INC. (MGRX).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing